Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...

Wondering if Astellas Pharma is still worth buying after its big run, or if the easy money has already been made? In this article, we walk through what the market is pricing in and where the gaps ...

The U.S. Court of Appeals for the First Circuit recently provided important clarity—and welcome relief—for clinical ...

Wondering if Nuvation Bio at around 8.66 is still a smart buy after its big run, or if most of the upside is already priced in? This article is designed to unpack that value question in plain English.

A precise platform for clinical gene editing Precision BioSciences is transforming drug development for new, potentially first- and best-in-class cell and gene therapies with its proprietary ARCUS ...

Background In December 2022, California prohibited the sale of most flavoured tobacco products; however, limited data are ...

Next year is bringing many changes to the regulatory landscape for skilled nursing. With new payment rules, coding changes ...

JEE Main 2026 Session 1 application correction window closes at 11.50 PM today Application correction window open for only registered candidates JEE Mains 2026 Session 1 Exams from January 21 to 30, ...